Deepak Nath - Abbott Laboratories Insider

Abbott Laboratories -- USA Stock  

USD 54.73  0.77  1.39%

Senior Vice President - Abbott Vascular

Mr. Deepak S. Nath is Senior Vice President Abbott Vascular of the Company. Currently he is Vice President, Vascular, Commercial. Between 2014 to 2015 he is Vice President, Molecular Diagnostics. Between 2012 to 2014 he is Divisional Vice President and General Manager, Ibis. Between 2011 to 2012 he is Divisional Vice President, CEEMEA, Vascular. Between 2009 to 2011 he is Divisional Vice President and General Manager, Nordics and Eastern European Operations, Vascular.
Age: 43  President Since 2015      
224 667-6100

Deepak Nath Latest Insider Activity

Management Efficiency

The company has Return on Asset of 3.43 % which means that on every $100 spent on asset it made $3.43 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 7.46 % implying that it generated $7.46 on every 100 dollars invested.
The company has 24.08 B in debt with debt to equity (D/E) ratio of 74.7 . This implies that the company may be unable to create cash to meet all of its financial commitments. Abbott Laboratories has Current Ratio of 2.64 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.

Similar Executives

Showing few of many executives


John HertiaBio Rad Laboratories Inc
Michael PariniVertex Pharmaceuticals Incorpor
Jonathon KellermanAllergan plc
Shawn SoderbergBio Rad Laboratories Inc
Michael PartridgeVertex Pharmaceuticals Incorpor
Matthew MalettaEndo International plc
Camille FarhatEndo International plc
Timothy ErnstBio Rad Laboratories Inc
Philippe SchaisonAllergan plc
Shannon HallBio Rad Laboratories Inc
Ronald HuttonBio Rad Laboratories Inc
Robert StewartAllergan plc
Paul NavarreAllergan plc
Thomas GraneyVertex Pharmaceuticals Incorpor
Amit SachdevVertex Pharmaceuticals Incorpor
Michael CrowleyBio Rad Laboratories Inc
Jeffrey ChodakewitzVertex Pharmaceuticals Incorpor
Antonio PeraEndo International plc
Blaise ColemanEndo International plc
William MeuryAllergan plc
Brian LortieEndo International plc

Entity Summary

Abbott Laboratories manufactures and sells health care solutions worldwide. Abbott Laboratories (ABT) is traded on New York Stock Exchange in USA. It is located in ILLINOIS, U.S.A and employs 74,000 people. Abbott Laboratories is listed under Pharmaceutical Products category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Abbott Laboratories to your portfolio

Top Management

Abbott Laboratories Leadership Team
Scott White, President
Samuel Scott, Director
Deepak Nath, President
Jaime Contreras, President
Roger Bird, President
Nancy McKinstry, Director
Heather Mason, President
James Farrell, Director
J White, President
Phebe Novakovic, Director
JeanYves Pavee, President
Andrew Lane, President
Roxanne Austin, Director
Georges Vos, President
Stephen Fussell, President
Thomas Freyman, EVP
Sally Blount, Director
Daniel Starks, Director
Thomas Frinzi, President
Eric Fain, President
John Capek, EVP
Robert Alpern, Director, Ph.D
Murthy Simhambhatla, President
Miles White, Chairman
Robert Ford, President
Glenn Tilton, Director
Richard Ashley, EVP
Michael Rousseau, President
Edward Liddy, Director
Hubert Allen, EVP
Charles Foltz, President
Brian Yoor, CFO
John Stratton, Director
Joseph Manning, President
Jared Watkin, President
William Osborn, Director
Brian Blaser, EVP
Michael Warmuth, President
Robert Funck, President
Daniel Salvadori, President
W Farrell, Director

Stock Performance

Abbott Laboratories Performance Indicators